PAHC
Phibro Animal Health Corporation
NASDAQ · USHealthcareDrug Manufacturers - Specialty & Generic
$33.05-0.78%
Price as of Jul 20, 2026
PAHC profitability
Phibro Animal Health Corporation profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 32.5%
- EBITDA margin
- 15.0%
- EBIT margin
- 12.3%
- Net margin
- 6.3%
- Free cash flow margin
- 0.9%
Returns
- Return on equity
- 26.3%
- Return on assets
- 6.6%
- Return on invested capital
- 16.0%
- Asset turnover
- 1.05x
Cash efficiency
- Cash from operations
- $66.1M
- Cash per share
- $1.91
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.